A New Therapy Option for the Management of Atopic Dermatitis in Pediatric Patients
Course Objectives:
This CME activity is intended for dermatologists, primary care
physicians, family practice physicians and pediatricians.
Upon completing this CME-certified monograph, you should be able to:
- Describe the efficacy and safety of new topical corticosteroid formulations
for treatment of atopic dermatitis in pediatric patients. - Compare and contrast the safety profiles of topical therapies for treatment
of atopic dermatitis in pediatric patients.
Accreditation:
This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by
Mark A. Gendreau, MD;
Abigail Zavod,MD,MPH;
Paula Brathwaite,MD
Release Date: March 2008
Expiration Date: March 31, 2009
Millennium CME Institute, Inc., is accredited by the ACCME to provide continuing
medical education for physicians. Millennium CME Institute, Inc., designates this CME-certified monograph for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure:
Millennium CME Institute, Inc., endorses the Accreditation Council for
Continuing Medical Education (ACCME) Standards for Commercial Support.
All faculty are required to disclose any commercial relationships or personal benefit with companies whose products are discussed in educational presentations and with companies who have provided the commercial support for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that
might be of potential importance to their evaluation of a presentation.
The faculty listed below have declared that they have no relationships to disclose:
Paula Brathwaite,MD
Tim I. Robinson
Mark A.Gendreau,MD
Abigail Zavod,MD,MPH
Signed disclosure forms are on file at Millennium CME Institute, Inc.
Off-label Usage Disclosure
This CME activity does not contain information on commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Directions:
The learner should read the learning objectives and review the activity in its
entirety. After reviewing the material, the learner should complete the Activity
Self-assessment Test consisting of a series of multiple-choice questions.
Upon successfully completing this activity as designed and achieving a passing
score of 70% or higher on the Activity Self-assessment Test, participants will
receive a continuing education credit letter awarding the appropriate credit
and the Activity Self-assessment Test answers four to six weeks after the receipt
of the registration and evaluation materials.
Estimated time to complete this CME-certified monograph as designed is .5 hours.
CME Testing Options
                    



